ID   HS71B_RAT               Reviewed;         641 AA.
AC   P0DMW1; P42853; Q07439; Q63256;
DT   27-MAY-2015, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2015, sequence version 1.
DT   24-JUL-2024, entry version 64.
DE   RecName: Full=Heat shock 70 kDa protein 1B;
DE   AltName: Full=Heat shock 70 kDa protein 1;
DE            Short=HSP70-1;
DE            Short=HSP70.1;
GN   Name=Hspa1b; Synonyms=Hsp70-2, Hspa2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8271311; DOI=10.1002/jnr.490360310;
RA   Longo F.M., Wang S., Narasimhan P., Zhang J.S., Chen J., Massa S.M.,
RA   Sharp F.R.;
RT   "cDNA cloning and expression of stress-inducible rat hsp70 in normal and
RT   injured rat brain.";
RL   J. Neurosci. Res. 36:325-335(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8086479; DOI=10.1016/0167-4781(94)90247-x;
RA   Lisowska K., Krawczyk Z., Widlak W., Wolniczek P., Wisniewski J.;
RT   "Cloning, nucleotide sequence and expression of rat heat inducible hsp70
RT   gene.";
RL   Biochim. Biophys. Acta 1219:64-72(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar; TISSUE=Spleen;
RX   PubMed=8141767; DOI=10.1042/bj2980561;
RA   Mestril R., Chi S.H., Sayen M.R., Dillmann W.H.;
RT   "Isolation of a novel inducible rat heat shock protein (HSP70) gene and its
RT   expression during ischaemia/hypoxia and heat shock.";
RL   Biochem. J. 298:561-569(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=LEW.1W/GUN;
RX   PubMed=7927536; DOI=10.1007/bf01246673;
RA   Walter L., Rauh F., Guenther E.;
RT   "Comparative analysis of the three major histocompatibility complex-linked
RT   heat shock protein 70 (Hsp70) genes of the rat.";
RL   Immunogenetics 40:325-330(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15060004; DOI=10.1101/gr.1987704;
RA   Hurt P., Walter L., Sudbrak R., Klages S., Mueller I., Shiina T., Inoko H.,
RA   Lehrach H., Guenther E., Reinhardt R., Himmelbauer H.;
RT   "The genomic sequence and comparative analysis of the rat major
RT   histocompatibility complex.";
RL   Genome Res. 14:631-639(2004).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of cellular
CC       processes, including protection of the proteome from stress, folding
CC       and transport of newly synthesized polypeptides, activation of
CC       proteolysis of misfolded proteins and the formation and dissociation of
CC       protein complexes. Plays a pivotal role in the protein quality control
CC       system, ensuring the correct folding of proteins, the re-folding of
CC       misfolded proteins and controlling the targeting of proteins for
CC       subsequent degradation. This is achieved through cycles of ATP binding,
CC       ATP hydrolysis and ADP release, mediated by co-chaperones. The co-
CC       chaperones have been shown to not only regulate different steps of the
CC       ATPase cycle, but they also have an individual specificity such that
CC       one co-chaperone may promote folding of a substrate while another may
CC       promote degradation. The affinity for polypeptides is regulated by its
CC       nucleotide bound state. In the ATP-bound form, it has a low affinity
CC       for substrate proteins. However, upon hydrolysis of the ATP to ADP, it
CC       undergoes a conformational change that increases its affinity for
CC       substrate proteins. It goes through repeated cycles of ATP hydrolysis
CC       and nucleotide exchange, which permits cycles of substrate binding and
CC       release. The co-chaperones are of three types: J-domain co-chaperones
CC       such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide
CC       exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70
CC       from the ADP-bound to the ATP-bound state thereby promoting substrate
CC       release), and the TPR domain chaperones such as HOPX and STUB1.
CC       Maintains protein homeostasis during cellular stress through two
CC       opposing mechanisms: protein refolding and degradation. Its
CC       acetylation/deacetylation state determines whether it functions in
CC       protein refolding or protein degradation by controlling the competitive
CC       binding of co-chaperones HOPX and STUB1. During the early stress
CC       response, the acetylated form binds to HOPX which assists in chaperone-
CC       mediated protein refolding, thereafter, it is deacetylated and binds to
CC       ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein
CC       degradation. Regulates centrosome integrity during mitosis, and is
CC       required for the maintenance of a functional mitotic centrosome that
CC       supports the assembly of a bipolar mitotic spindle. Enhances STUB1-
CC       mediated SMAD3 ubiquitination and degradation and facilitates STUB1-
CC       mediated inhibition of TGF-beta signaling. Essential for STUB1-mediated
CC       ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg)
CC       during inflammation. {ECO:0000250|UniProtKB:P0DMV9}.
CC   -!- SUBUNIT: May be an auxiliary component of the CatSper complex.
CC       Identified in a IGF2BP1-dependent mRNP granule complex containing
CC       untranslated mRNAs. Interacts with CHCHD3, DNAJC7, IRAK1BP1, PPP5C and
CC       TSC2. Interacts with TERT; the interaction occurs in the absence of the
CC       RNA component, TERC, and dissociates once the TERT complex has formed.
CC       Interacts with METTL21A. Interacts with TRIM5 (via B30.2/SPRY domain).
CC       Interacts with PRKN. Interacts with FOXP3. Interacts with NOD2; the
CC       interaction enhances NOD2 stability. Interacts with DNAJC9 (via J
CC       domain). Interacts with ATF5; the interaction protects ATF5 from
CC       degradation via proteasome-dependent and caspase-dependent processes.
CC       Interacts with NAA10, HSP40, HSP90 and HDAC4. The acetylated form and
CC       the non-acetylated form interact with HOPX and STUB1 respectively.
CC       Interacts with NEDD1 and SMAD3. Interacts (via NBD) with BAG1, BAG2,
CC       BAG3 and HSPH1/HSP105. Interacts with DNAJC8.
CC       {ECO:0000250|UniProtKB:P0DMV9}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P0DMV9}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000250|UniProtKB:P0DMV9}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs. {ECO:0000250|UniProtKB:P0DMV9}.
CC   -!- TISSUE SPECIFICITY: HSPA1B is testis-specific.
CC   -!- INDUCTION: By heat shock.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known as
CC       the ATPase domain) is responsible for binding and hydrolyzing ATP. The
CC       C-terminal substrate-binding domain (SBD) (also known as peptide-
CC       binding domain) binds to the client/substrate proteins. The two domains
CC       are allosterically coupled so that, when ATP is bound to the NBD, the
CC       SBD binds relatively weakly to clients. When ADP is bound in the NBD, a
CC       conformational change enhances the affinity of the SBD for client
CC       proteins. {ECO:0000250|UniProtKB:P0DMV9}.
CC   -!- PTM: In response to cellular stress, acetylated at Lys-77 by NA110 and
CC       then gradually deacetylated by HDAC4 at later stages. Acetylation
CC       enhances its chaperone activity and also determines whether it will
CC       function as a chaperone for protein refolding or degradation by
CC       controlling its binding to co-chaperones HOPX and STUB1. The acetylated
CC       form and the non-acetylated form bind to HOPX and STUB1 respectively.
CC       Acetylation also protects cells against various types of cellular
CC       stress. {ECO:0000250|UniProtKB:P0DMV9}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L16764; AAA17441.1; -; mRNA.
DR   EMBL; X74271; CAA52328.1; -; Genomic_DNA.
DR   EMBL; X75357; CAA53140.1; -; Genomic_DNA.
DR   EMBL; X77207; CAA54422.1; -; Genomic_DNA.
DR   EMBL; BX883045; CAE83977.1; -; Genomic_DNA.
DR   PIR; I54542; I54542.
DR   RefSeq; NP_001316825.1; NM_001329896.1.
DR   RefSeq; NP_114177.2; NM_031971.2.
DR   RefSeq; NP_997669.1; NM_212504.1.
DR   RefSeq; XP_017457331.1; XM_017601842.1.
DR   AlphaFoldDB; P0DMW1; -.
DR   SMR; P0DMW1; -.
DR   jPOST; P0DMW1; -.
DR   DNASU; 24472; -.
DR   GeneID; 108348108; -.
DR   GeneID; 24472; -.
DR   KEGG; rno:108348108; -.
DR   KEGG; rno:24472; -.
DR   AGR; RGD:1593284; -.
DR   AGR; RGD:2840; -.
DR   CTD; 3303; -.
DR   CTD; 3304; -.
DR   RGD; 2840; Hspa1b.
DR   VEuPathDB; HostDB:ENSRNOG00000045654; -.
DR   VEuPathDB; HostDB:ENSRNOG00000050647; -.
DR   InParanoid; P0DMW1; -.
DR   OrthoDB; 143at2759; -.
DR   PhylomeDB; P0DMW1; -.
DR   Reactome; R-RNO-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-RNO-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-RNO-3371568; Attenuation phase.
DR   Reactome; R-RNO-3371571; HSF1-dependent transactivation.
DR   Reactome; R-RNO-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   PRO; PR:P0DMW1; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000045654; Expressed in esophagus and 17 other cell types or tissues.
DR   ExpressionAtlas; P0DMW1; baseline and differential.
DR   GO; GO:0016235; C:aggresome; ISO:RGD.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0005814; C:centriole; ISO:RGD.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0008180; C:COP9 signalosome; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0016234; C:inclusion body; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:CAFA.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISO:RGD.
DR   GO; GO:0002199; C:zona pellucida receptor complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0016887; F:ATP hydrolysis activity; ISO:RGD.
DR   GO; GO:0140545; F:ATP-dependent protein disaggregase activity; ISO:RGD.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; ISO:RGD.
DR   GO; GO:0038177; F:death receptor agonist activity; ISO:RGD.
DR   GO; GO:0031249; F:denatured protein binding; ISO:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; ISO:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0051787; F:misfolded protein binding; ISO:RGD.
DR   GO; GO:0051059; F:NF-kappaB binding; IPI:RGD.
DR   GO; GO:0002020; F:protease binding; IPI:RGD.
DR   GO; GO:0044183; F:protein folding chaperone; ISO:RGD.
DR   GO; GO:0048018; F:receptor ligand activity; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0140416; F:transcription regulator inhibitor activity; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0051082; F:unfolded protein binding; ISO:RGD.
DR   GO; GO:0046034; P:ATP metabolic process; ISO:RGD.
DR   GO; GO:0007339; P:binding of sperm to zona pellucida; ISO:RGD.
DR   GO; GO:0070370; P:cellular heat acclimation; ISO:RGD.
DR   GO; GO:0034605; P:cellular response to heat; ISO:RGD.
DR   GO; GO:0034620; P:cellular response to unfolded protein; ISO:RGD.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IBA:GO_Central.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; ISO:RGD.
DR   GO; GO:0006952; P:defense response; IDA:RGD.
DR   GO; GO:0006402; P:mRNA catabolic process; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0090084; P:negative regulation of inclusion body assembly; ISO:RGD.
DR   GO; GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045906; P:negative regulation of vasoconstriction; IMP:RGD.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISO:RGD.
DR   GO; GO:0090063; P:positive regulation of microtubule nucleation; ISS:UniProtKB.
DR   GO; GO:0070434; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; ISO:RGD.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0033120; P:positive regulation of RNA splicing; ISO:RGD.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:RGD.
DR   GO; GO:1903265; P:positive regulation of tumor necrosis factor-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0006457; P:protein folding; ISO:RGD.
DR   GO; GO:0042026; P:protein refolding; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; ISS:UniProtKB.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0009408; P:response to heat; ISO:RGD.
DR   GO; GO:0006986; P:response to unfolded protein; IMP:RGD.
DR   CDD; cd10233; HSPA1-2_6-8-like_NBD; 1.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 3.30.30.30; -; 1.
DR   Gene3D; 3.30.420.40; -; 2.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375:SF223; HEAT SHOCK 70 KDA PROTEIN 1A-RELATED; 1.
DR   PANTHER; PTHR19375; HEAT SHOCK PROTEIN 70KDA; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   SUPFAM; SSF100934; Heat shock protein 70kD (HSP70), C-terminal subdomain; 1.
DR   SUPFAM; SSF100920; Heat shock protein 70kD (HSP70), peptide-binding domain; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; ATP-binding; Chaperone; Cytoplasm; Cytoskeleton; Methylation;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Stress response.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   CHAIN           2..641
FT                   /note="Heat shock 70 kDa protein 1B"
FT                   /id="PRO_0000433116"
FT   REGION          2..386
FT                   /note="Nucleotide-binding domain (NBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          394..509
FT                   /note="Substrate-binding domain (SBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          618..641
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         12..15
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         71
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         202..204
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         268..275
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         339..342
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         77
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         108
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         246
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         348
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         469
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         561
FT                   /note="N6,N6,N6-trimethyllysine; by METTL21A; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         561
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         631
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         633
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   MOD_RES         636
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV9"
FT   CONFLICT        71..72
FT                   /note="KR -> NG (in Ref. 2; CAA52328 and 3; CAA53140)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        110
FT                   /note="E -> K (in Ref. 3; CAA53140)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="T -> R (in Ref. 3; CAA53140)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="H -> D (in Ref. 1; AAA17441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        262..267
FT                   /note="RLRTAC -> PLADGV (in Ref. 3; CAA53140)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        408
FT                   /note="G -> A (in Ref. 2; CAA52328)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   641 AA;  70185 MW;  2D745B1013F64E7B CRC64;
     MAKKTAIGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     LNPQNTVFDA KRLIGRKFGD PVVQSDMKHW PFQVVNDGDK PKVQVNYKGE NRSFYPEEIS
     SMVLTKMKEI AEAYLGHPVT NAVITVPAYF NDSQRQATKD AGVIAGLNVL RIINEPTAAA
     IAYGLDRTGK GERNVLIFDL GGGTFDVSIL TIDDGIFEVK ATAGDTHLGG EDFDNRLVSH
     FVEEFKRKHK KDISQNKRAV RRLRTACERA KRTLSSSTQA SLEIDSLFEG IDFYTSITRA
     RFEELCSDLF RGTLEPVEKA LRDAKLDKAQ IHDLVLVGGS TRIPKVQKLL QDFFNGRDLN
     KSINPDEAVA YGAAVQAAIL MGDKSENVQD LLLLDVAPLS LGLETAGGVM TALIKRNSTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT RDNNLLGRFE LSGIPPAPRG VPQIEVTFDI
     DANGILNVTA TDKSTGKANK ITITNDKGRL SKEEIERMVQ EAERYKAEDE VQRERVAAKN
     ALESYAFNMK SAVEDEGLKG KISEADKKKV LDKCQEVISW LDSNTLAEKE EFVHKREELE
     RVCNPIISGL YQGAGAPGAG GFGAQAPKGG SGSGPTIEEV D
//
